Nanhua Bio-Medicine Co., Ltd. logo

Nanhua Bio-Medicine Co., Ltd.

000504 · SZSE · China

landfar.cn

Financials as of FY2025

What stands out
  • Revenue is growing, but receivables have grown faster over the last six to eight years
  • Earnings significantly exceed cash generation
At a glance
  • Depends onUpstream position: supplies 6 industries, depends on 3
  • PositionGross margin is 2.9%, lower than 95% of its Biotechnology peers (median 65.4%)
  • FinancialsAltman Z-Score 2.25: grey zone
  • Interpretations2 currently firing — 2